Directory · CN
Biotechnology in China
A register of firms and the professionals working at them in the Biotechnology sector based in China. Browse the public index, then filter or export on Kipplo.
Companies
312 on file
Jw Therapeutics
JW Therapeutics (HKEx: 2126) is an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products. Since its founding in 2016, the company has built an integrated platform and pipeline spanning hematologic malignancies, solid tumors and autoimmune diseases. As a commercial-stage CAR-T company, JW Therapeutics is committed to bringing breakthrough, high-quality cell therapies such as Carteyva® to patients in China and beyond, improving survival and quality of life and advancing the healthy, standardized development of the cell therapy industry.
201 to 500 staff
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015, the company is focused on creating safe, scalable, and accessible therapies that eliminate traditional barriers to CAR-T treatment. Headquartered in West Palm Beach, Florida with operations across the Cayman Islands and Asia, EXUMA takes a globally integrated approach to science and development. Our mission is to create safe, effective, and accessible therapies through platforms designed for high-throughput discovery, tumor-specific targeting, and point-of-care delivery.
51 to 200 staff
Angel Yeast Fermentation Nutrients
To satisfy the needs for organic nitrogen sources in the bio-fermentation industry, including fermentation of biological pharmaceuticals, amino acids, probiotics, enzymes, etc, Angel Yeast has developed safe, efficient, clean, stable yeast extracts, yeast peptone, inactive yeast, and culture media. https://en.angelyeast.com/products/microbial-nutrition.html
10001+ staff
Bota Biosciences
Bota Biosciences (Bota Bio) is a global industrial biotechnology company connecting biological design to scale-up manufacturing to accelerate shifts to sustainable living. Bota has built an integrative bioengineering platform, to develop and implement efficient, eco-friendly, and cost-effective biomanufacturing technologies. Committed to its mission, Bota established its own pilot plant and manufacturing facility, affirming its dedication to offering scalable industrial solutions and market-ready products. This infrastructure strengthens support for customers and partners across industries such as nutrition, food, personal care, and animal health. Powered by a dynamic, multidisciplinary team, Bota Bio channels biotech innovations to create a global impact. The company's Series B financing has surpassed $100 million, bringing its aggregate funding to $145 million, with investment from notable strategic and financial investors, including Hong Shan Capital, Matrix Partners, and BASF Ventures.
51 to 200 staff
Shanghai Junshi Biosciences Co Ltd
Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With distinguished capability of innovative drug discovery, advanced biotechnological R&D, large-scale production capacity on the full industry chain and rapidly expanding drug candidate portfolio of tremendous market potential, Junshi has a leading edge in the PRC in the emerging field of immuno-oncology and for the treatment of autoimmune and metabolic diseases. Junshi is the first PRC company filing IND application and NDA application to the NMPA for anti-PD-1 monoclonal antibody, and also the first PRC company to receive IND approvals from the NMPA for anti-PCSK9 monoclonal antibody and anti-BLyS monoclonal antibody. Our vision is to become a pioneer in the area of translational medicine by developing first-in-class and best-in-class drugs through original innovation. With enrichment of our product pipelines and exploration of drug combination therapies, Junshi expanded its innovation to the R&D of more types of drugs, including small molecule drugs and antibody drug conjugates (or ADCs), as well as to the exploration of the next-generation innovative therapies for cancer and autoimmune diseases.
1001 to 5000 staff
Bioeasy Biotechnology
Shenzhen Bioeasy Biotechnology Inc, a leading provider of food safety, animal health and public health products. We are dedicated to provide the easy, simple, reliable, quality assurance and affordable rapid test to the global market for over 15 years, and help people have easy access to those reliable food diagnostics, animal diagnostics and clinical diagnostics products on time! Advantages- Strong R&D - insists on the way of self-innovation and steadily development- Reliable and high quality products, obtain CE, FDA, CLIA WAIVED, AQSIQ qualification, certificated by AOAC, ILVO and others- OEM - Ideal for exporters to China
501 to 1000 staff
Dalian Polytechnic University
Dalian Polytechnic University, formerly known as Dalian Institute of Light Industry, is the key construction university of Liaoning Province, “Excellence Plan” and “2011 Plan”, and the first batch of pilot universities for the reform of agricultural and forestry personnel education and training plan. Founded in 1958, the school was one of the first four light industry colleges established in China. It was originally affiliated to the Ministry of Light Industry and was placed under the administration of Liaoning Province in 1998.
10001+ staff
Hsf Biotech
As a high-tech biotechnology company, HSF Biotech is high-quality ingredient solutions manufacturer for human better life. Based on R&D and innovation, We serve multiple industries, such as dietary supplements, food and beverage, pharmaceutics, personal care products, animal nutrition in the global markets. As one of the global plant sterols/esters suppliers, HSF is an important pioneer in China's phytosterol/ester industry, a market promoter and a participant in the formulation of national industry standards. In 2022, HSF launched new innovations on fermentation technology, which have created a rapid and healthy growth in global reputation and technology accumulation. Covered Products Fermtek™ Fermentation Series | LowChol™ Phytosterol | VegeToco™ Natural Vitamin E | VegeLipi™ Micro-encapsulated Lipid Powder | SoliPro™ Micro-encapsulated Solid Powder | NatenFla™ Natural Flavors | VegeNutri™ Nutrition Ingredients | NutraColor™ Natural Color | NatoDant™ Natural Anti-Oxidant | PhytoSweet™ Sweeteners Our products cover the research and development, manufacture and sales of a multiple series of products: plant sterols/esters, natural vitamin E, functional powder/oil microencapsulation, natural pigments, fermenation product and ferulic acid. HSF is certified with the ISO 9001 standard and ISO FAMI-QS, SC, HALAL, Kosher, IP(NON-GMO), cGMP and ORGANIC(NOP/EOS), etc. Product Development & Solution Contract Manufacturing | Customized Ingredients Solution | Blend and Premix | Patenting and Functional Evaluation Providing systematic product solutions to global customers in the nutrition and health field. HSF has a number of independent R&D and industrialization technical teams. We have core patented technologies in a number of cutting-edge biotechnology and life science fields. HSF is committed to taking the road of technological innovation and technology first.
51 to 200 staff
Carterra
Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSA-XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSA-XT and Ultra instruments introduce enhancements to Carterra’s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. For additional information, please visit
51 to 200 staff
Chongqing Zhifei Biological Products Co., Ltd
Chongqing Zhifei Biological Products is a biotechnology company based out of CHONGQING, CQ | Chongqing, China.
1 to 10 staff
Bsbe
BSBE is a Chinese leading provider of in-vitro diagnostics (IVD) products and service, there are biochemistry reagents, coaguation reagents and instrument, blood grouping cards and instrument, etc. BSBE was established in 2001, focusing on R&D, manufacturing and sales of IVD products which reach to international advanced level. BSBE was registered in Beijing, the capital of China with the registered capital of RMB501,787,943 and successfully listed on GEM in Shenzhen with the stock code 300406 in 2014. As a Chinese leader in IVD filed, BSBE is engaged in developing the best IVD testing platform. And till now, BSBE has the system of clinical biochemistry testing, coagulation testing and blood typing. Due to the steady progression and rich experience in the years, BSBE has a worldwide sales and marketing network. BSBE is focused on the R&D of IVD products and it has a high qualified R&D team. Under the guidance of the experts, BSBE has established clinical biochemistry platform of enzymatic method (including enzymatic cycling method), immunoturbidimetric method, latex immunoturbidimetric method, CEDIA method, EMIT method; Meanwhile, BSBE has very strong R&D team on liquid coagulation reagents. In 2018, BSBE launches its blood typing system using the DG Gel card technology.
501 to 1000 staff
Sironax
Sironax is a global clinical-stage biotechnology company committed to promoting healthier aging by discovering and developing novel treatments for degenerative diseases affecting longevity, diseases requiring supportive care, and certain autoimmune immunology and inflammation diseases. Sironax has three proprietary clinical-stage programs with first-in-class or best-in-class assets, and several undisclosed preclinical programs. The company’s research targets key contributors of aging: dysregulated cellular death, uncontrolled inflammation, and disrupted energy homeostasis. Sironax is headquartered in Waltham, Massachusetts, with comprehensive research centers in Beijing and Shanghai, China, and additional operations in Basel, Switzerland and Sydney, Australia. For more information, visit sironax.com.
51 to 200 staff
Jland Biotech
Jiangsu Jland Biotech Co, Ltd is a company dedicated to the development and production of Biollagen™ collagen. We design and develop Pichia engineering yeast and aim at improving hydrophilicity and eliminating immunogenicity. Non-Animal derived collagen has many advantages over animal-derived collagen & has multiple applications in cosmetic & Pharmaceutical applications
201 to 500 staff
Obio Tech
Established in 2013, OBiO Technology leads the way in gene and cell therapy as a pioneering CRO and CDMO. Our expertise spans vectorology studies, functional genomics, PD, AD, GMP production, as well as IND-enabling CMC and clinical and commercial manufacturing, provides comprehensive solutions internationally and tailored services for your needs. 🧬 GMP production: State-of-the-art ft 2) facility for global supply. 🧬 We specialize in vectorology studies, functional genomics, PD and AD, ensuring Investigational New Drug (IND) readiness and supporting all phases of clinical and commercial manufacturing. 🧬 From laboratory to clinic, we continuously advance your products, positively impacting populations worldwide. 🧬 Our unwavering commitment ensures the delivery of high quality CDMO services across the preclinical, IND, clinical, and commercial stages. 🧬Our expertise spans plasmids, mRNA, AAV, LVV, Ad viral vectors, cell therapy, CAR-T, NK, Treg, iPSCs, Exosome.Oncolytic virus, as well as cutting-edge technologies like inducible viral vector packaging, ultralow endotoxin processes, and AAVneo for tissue-specific AAV variants, etc. 🧬Trustful Expertise: 10+ years experience in Cell & Gene Therapy, over 40% master degree above holders. Do not hesitate to send an inquiry or question here: https://lnkd.in/g8BzXQfQ Phone:++1 781-748-4204 (U.S.) Email: bd@obiosh.com
501 to 1000 staff
Affamed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.
51 to 200 staff
Kdn Biotech Shanghai Co., Ltd
Welcome to KDN Shanghai, where we are hard at work every day to replace traditional industrial processes with sustainable, environmentally-friendly and more innovative solutions. We owe it to the earth to do so. KDN Biotech is a leading enzyme company that specializes in the research, development, and manufacturing of high-quality enzymes for a variety of industries, including textile, household care, bioenergy, pulp & paper, animal nutrition, food enzyme. With a strong focus on innovation, quality, and customer satisfaction, KDN Biotech has earned a reputation as a trusted supplier of enzymes that meet the most demanding standards. Founded by a team of experienced scientists and entrepreneurs, KDN Biotech has 9 production bases, 8 technical centers, 2 laboratories, 32 Ph.Ds and about 300 Masters. This has enabled the company to develop a broad range of enzymes that can be customized to meet the specific needs of its customers. KDN Biotech's product portfolio includes a wide range of enzymes, including proteases, lipases, cellulase and specialty enzymes. At KDN Biotech, we are committed to sustainability and responsible manufacturing practices. Our enzymes are produced using eco-friendly processes and are derived from non-GMO sources. We strive to minimize our environmental impact and promote a sustainable future for all.
1001 to 5000 staff
Mytech
Chengdu Mytech Biotech Co, Ltd, Mytech in short, was founded in 2003 by a group of entrepreneurs with the ambition to become the world’s outstanding supplier of small peptides. In 2006, Mytech speed up its steps into global market. Mytech aims to provide better service to animal husbandry field and become a globalized animal nutrition company. The production line of Mytech is in compliance with GMP+ standard to ensure its better production process and good product quality. Nowadays, Mytech invested lots of efforts and funds on product development and application study, aiming to make better localization of product in different areas. Better for Animals Better for Human
51 to 200 staff
Pangoo Focus On Animal Natural Health
Business Type: Manufacturer, Trading Company Location: Hebei, China (Mainland) Main Products: Mycotoxin treatment,Pond Cleaner,Feed Probiotics,Feed Additives,Animal Supplement Total Employees: 501 - People Total Annual Revenue: Above US$100 Million Year Established: 2010 Top 3 Markets: Africa 23.00% Mid East 19.00% Southeast Asia 15.00% Certifications: ISO9001,ISO9001,FSC Product Certifications: Audited Supplier PANGOO - specialized taking care animal Health! Company philosophy: integrity deeds and thanksgiving society Factory was found in 1993. Registered Capital: RMB Fixed Asset: RMB Production Ability: MT / Year Certificates: Certificate of Food safety Management System Certification Certificates: Quality Managements System Certificate ISO 9001:2008 10615Q10106ROS Scientific research achievements: Development concept: Development green industry, to promote human health! Assumed the national "863" project of " Research bacteria and algae repair freshwater environment "" Genetically engineered bacteria to repair Pond Environmental Application Technology and Demonstration ", the project have won the "Hebei Science and Technology Progress Second Award"; Optional subjects of "The Study of Pro-Niceclean and Nitrate Treatment, and The technical research of ammonia, nitrite degradation"" The development and application of Construction of series probiotics for pond water phase", the subject have passed the provincial appraisal, and achieved to provincial and municipal science and technology progress awards. In 2011, in collaboration with the Chinese academy of sciences institute of Marine, shared the country's "12th five-year" science and technology support projects, namely the key technology research of Maritime Affairs and Fisheries Disease Prevention and Control (2011BAZ02709) October 18, 2013," The Development and Application of Viable particles sediment improver "" The development and application of Biological agents to destroy cyanobacteria "these two projects have been identified by the provincial level, and achieved leading in the domestic. Viable particles improved the pond bottom, the biological elimination of cyanobacteria and other products, the process and equipment of domestic initiative of liquid and solid, fully automatic fermentation, which has declared three national patents. Honor: Winning mentality: Proud of Pangoo! The advanced collective of national feed industry and technological progress High-tech biotechnology companies Key leading enterprises in agricultural industrialization management grade credit enterprise in Hebei Province The most popular Agricultural and Economics products for consumer In 2012, named science and technology innovation enterprise by Qingxian, and won the "Technology Innovation Award Top Ten integrity enterprises in Hebei Province At the same time, general manager lian shui Zhang was named "Outstanding scientific and technological leader"
51 to 200 staff
Tcrcure Biopharma Corp
TCRCure Biopharma Corp is a world-class, “One-Stop Shop” cell therapy operation built across the U.S. and China. We deliver the latest cell therapy advances directly to patients with solid tumors. As of 2021, we have treated more than 50 patients and built more than a dozen CAR-T/TCR-T pipelines. TCRCure’s cutting-edge platform technologies include antigen-specific TCR/CAR discovery, immune-cell engineering, and industry-scale viral vector production. We operate sq. ft. of specialized facilities on both sides of the Pacific, including scalable GMP capacity for cell production and viral manufacturing. TCRCure works closely with world-class hospitals in China and the United States for clinical research in different solid tumors. Current indications including cervical cancer, ovarian cancer, nasopharyngeal carcinoma, lung squamous carcinoma, melanoma, sarcoma, endometrial cancer, and brain cancer.
51 to 200 staff
Wesail Biotech
Company Introduction: WESAIL Biotech Contact Email: sales@wesailbio.com Wesail Biotech, with over 20 years of experience, is a leading innovator in the IVD industry, providing high-performance reagents and analyzers, including colloidal gold and immunofluorescence platforms. We specialize in POCT solutions for cardiovascular health, metabolism, fertility, inflammation, diabetes, hormones, and more. During the pandemic, our COVID-19 self-test kits gained global recognition, including: CE0123 Certification (TUV SUD), Germany PEI Approval, and French ANSM Registration. Our POCT products are widely used in emergencies. Cardiac markers high sensitive Troponin-I test in 8 mins in whole blood (no serum separation). HbA1c CV is within 5%. VD test takes 15 mins with both NGSP and IFCC certification. Our products are trusted across Europe, Latin America, and the Middle East, with leading hospitals in Italy recognizing their exceptional performance. We hold global certifications, including US FDA and European IVDR. As a global leader in the Point-of-Care Testing, Wesail Biotech is committed to pushing the boundaries of healthcare innovation to the next level.
51 to 200 staff
Acerchem International
As a leading group in Health & Nutraceutical industry, Acerchem provides a variety of solutions from innovative ingredients, contract manufacturing, supply chain, formulation, and capsules. Our business is covering more than 40 countries in nutritional supplement, functional foods and beverage, beauty care and animal nutrition markets. Our offices in UK, Japan, Netherlands, Spain have contributed in an extensive way to local Health & Nutraceutical industry. We keep our mission "Create value for health, Bring Nutrition to life" to all our customers, partners, and suppliers. Our global souring and supply chain service have brought splendid value to our customers, with JIT delivery, strict quality control, and passionate after-sales service.
51 to 200 staff
Anhui Huaheng Biotechnology Co., Ltd
Key words: AMINO ACID, ALANINE, ARBUTIN, MANUFACTURER. Anhui Huaheng Biological Engineering Co, Ltd. was established in April 2005, is a professional engaged in amino acids and other organic acid product development, production and sales of national Torch key high-tech enterprises. The company has successfully undertaken the "863" project of the Ministry of Science and Technology of the Twelfth Five-Year Plan, the National Demonstration Project of the Biological Industry of the National Develop mentand Reform Commission, the Enterprise Technology Innovation Fund of the Ministry of Science and Technology, and other high-tech industrialization projects. It is an international leader in the production of L-Alanine technology and industrialization of enterprises. Our products are mainly used in medicine and health care products, daily chemicals,food and food additives and other fields.Upholdingthe concept of green, relying on technological breakthroughs and cost advantages, We providing services for the world's top 500 and industry leaders, including many domestic and international first-class customers.
501 to 1000 staff
Biosino Bio-Technology & Science Inc
BioSino is a leading high-technology enterprise whose major national controlling stakeholders comprise the Chinese Academy of Sciences, Beijing Municipal Government and Shanghai Municipal Government. Biosino has already become the largest manufacturer of IVD reagents in China after 20 years development. BioSino successfully finished IPO in GEM of Hong Kong Stock in 2006. Biosino's diagnostic products including clinical chemistry, immunology assay, molecular diagnostics, and rapid tests. BioSino has developed over 600 distributors and retailers over the China, occupy 75% of the Chinese market. The diagnostic products exported to over 50 countries from Southeast Asia, Middle-east, North Africa, and South America. BioSino has a professional after sales service team comprising experts in the field of biochemistry, immunology, pharmacy and medicine. It provide on-the-spot technological support and service to our customers, teach them how to use our products and resolve problems they meet.
201 to 500 staff
Changsha Comext Biotech Co.,ltd
Comext is an enterprise of raw materials supply to the health science area that encompasses Food, Nutraceutical, Pharmaceutical, Cosmetic, and Feed Additive markets. Our core competencies are the quality assurance and international regulatory support with the professional production and R&D team, and the solid cooperation with professional third-party labs, such as Eurofins, SGS, Pony, TUV and so on. We treat the Product Quality First, Customer Service Frist as our Business Value. Mission - To create value for customers by developing and supplying products with the best quality, service and price- To promote a corporate culture based on the daily effort, training, entrepreneurship and professionalism of the team, and an intensive R&D platform to develop proprietary products as drivers for growth- To contribute to improving quality of life by providing expertise and services in the development of affordable drugs that meet society´s needs.
51 to 200 staff
